Y-Mabs Therapeutics (YMAB) Return on Equity (ROE) (2018 - 2025)
Y-Mabs Therapeutics (YMAB) Return on Equity (ROE) from Sep 30, 2018 to Jun 30, 2025. The TTM Y-Mabs Therapeutics (YMAB) Return on Equity (ROE) is -3.70%. You can export chart.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Y-Mabs Therapeutics (YMAB)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2024 | -32.25% | +51.98% |
| 2023 | -21.22% | -75.75% |
| 2022 | -87.50% | +185.15% |
| 2021 | -30.69% | -72.78% |
| 2020 | -112.76% | +176.77% |
| 2019 | -40.74% | +32.31% |
| 2018 | -30.79% | N/A |